Generic Drugs Market Grow with a CAGR 2021-2027 Focuses On Top Companies Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi

Spread the love

According to QY Research Medical, the global Generic Drugs market size is projected to reach US$ 505220 million by 2026, from US$ 285180 million in 2019, at a CAGR of 10.0% during 2021-2027

This in-depth report encompasses comprehensive historical analysis as well as projections on an international and regional level for the Generic Drugs market. The research report offers quantitative information for the historic years from 2017 – 2021 together with the projections from 2021 to 2030 in order to provide the users with an extensive understanding of the global Generic Drugs market. Moreover, the study also provides driving as well as restraining factors for the global Generic Drugs market together with the impact of these factors on the overall demand for the products or services within the projected time-frame. The report includes Porter’s five forces analysis which gives the reader a detailed breakdown of the competitiveness within the industry.

The market estimation and projections are provided for the global market broken down into product type, application, regions and countries. The report offers a comprehensive analysis of the company market share for a clear understanding of the manufacturers operating in the global Generic Drugs market.

Download Sample – https://qyresearchmedical.com/sample/98919

The research methodology at Precedence Research involves data mining through extensive primary and secondary research. In primary research, senior executives of leading companies along with industry experts and subject specialists are contacted to get an accurate understanding of the market. The data gathered from primary participants is then validated through an in-depth secondary research. The current trends in healthcare industry are also analyzed as a part of the market estimation. A thorough analysis of this entire set of information enables an accurate estimation of the market.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analyzed and prime business strategies and products that offer high revenue generation capacities were indentified. Key players of the global Generic Drugs market are included as given below:

Teva
Novartis – Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Generic Drugs Breakdown Data by Type
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Generic Drugs Breakdown Data by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Download Full Report – https://qyresearchmedical.com/report/checkout/98919/3500

COVID-19 Pandemic: Impact analysis

The corona virus pandemic has tested the healthcare industry by presenting challenges such as speeding up research activities, expansion of manufacturing capacities, and supply chains. The sudden up burst in all sectors of pharmaceutical industry, has bought the attention of investors around the globe to this sector. The pharmaceutical and medical device manufacturers have realigned their strategies to deal with the pandemic situation in a better way. The development of vaccine against the corona virus in a record time-span is an accurate example of the steps taken by manufacturers to combat the pandemic. The development of multiple rapid testing methods for early detection of COVID-19 has also played a major role in containing the disease. The leading companies within healthcare domain are working with governments across the world to prepare an effective framework for avoidance of such pandemics in the future.

Significant Highlights of The Research Study:

  • A clear understanding of the current market trends as well as projections from 2017 – 2030
  • Qualitative analysis of the market including drivers, restraints, opportunities, and challenges
  • Multiple analysis models such as Porter’s Five Forces, PESTEL, and SWOT for a comprehensive study of the market
  • The competitive landscape with detailed company profiles and company market share breakdown
  • Crucial insights like the future prospects of the market which will dictate the strategies of market players
  • An exhaustive insight into the demand for Generic Drugs market in major regions and countries broken down into multiple segments

TABLE OF CONTENT

1 Study Coverage
1.1 Generic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Generic Drugs Market Size Growth Rate by Type
1.4.2 Simple Generic Drugs
1.4.3 Super Generic Drugs
1.2.4 Biosimilars
1.3 Market by Application
1.3.1 Global Generic Drugs Market Size Growth Rate by Application
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Generic Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Generic Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Generic Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Generic Drugs Regions by Sales
2.4.1 Global Top Generic Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Generic Drugs Regions by Sales (2022-2027)
2.5 Global Top Generic Drugs Regions by Revenue
2.5.1 Global Top Generic Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Generic Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Generic Drugs Sales by Manufacturers
3.1.1 Global Top Generic Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Generic Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Generic Drugs Sales in 2020
3.2 Global Generic Drugs Revenue by Manufacturers
3.2.1 Global Top Generic Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Generic Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2020
3.3 Global Generic Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Generic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Generic Drugs Sales by Type
4.1.1 Global Generic Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Generic Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Generic Drugs Sales Market Share by Type (2016-2027)
4.2 Global Generic Drugs Revenue by Type
4.2.1 Global Generic Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Generic Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Generic Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Generic Drugs Price by Type
4.3.1 Global Generic Drugs Price by Type (2016-2021)
4.3.2 Global Generic Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Generic Drugs Sales by Application
5.1.1 Global Generic Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Generic Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Generic Drugs Sales Market Share by Application (2016-2027)
5.2 Global Generic Drugs Revenue by Application
5.2.1 Global Generic Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Generic Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Generic Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Generic Drugs Price by Application
5.3.1 Global Generic Drugs Price by Application (2016-2021)
5.3.2 Global Generic Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Generic Drugs Market Size by Type
6.1.1 North America Generic Drugs Sales by Type (2016-2027)
6.1.2 North America Generic Drugs Revenue by Type (2016-2027)
6.2 North America Generic Drugs Market Size by Application
6.2.1 North America Generic Drugs Sales by Application (2016-2027)
6.2.2 North America Generic Drugs Revenue by Application (2016-2027)
6.3 North America Generic Drugs Market Size by Country
6.3.1 North America Generic Drugs Sales by Country (2016-2027)
6.3.2 North America Generic Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Generic Drugs Market Size by Type
7.1.1 Europe Generic Drugs Sales by Type (2017-2027)
7.1.2 Europe Generic Drugs Revenue by Type (2017-2027)
7.2 Europe Generic Drugs Market Size by Application
7.2.1 Europe Generic Drugs Sales by Application (2017-2027)
7.2.2 Europe Generic Drugs Revenue by Application (2017-2027)
7.3 Europe Generic Drugs Market Size by Country
7.3.1 Europe Generic Drugs Sales by Country (2017-2027)
7.3.2 Europe Generic Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Generic Drugs Market Size by Type
8.1.1 Asia Pacific Generic Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Generic Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Generic Drugs Market Size by Application
8.2.1 Asia Pacific Generic Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Generic Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Generic Drugs Market Size by Region
8.3.1 Asia Pacific Generic Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Generic Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Generic Drugs Market Size by Type
9.1.1 Latin America Generic Drugs Sales by Type (2019-2027)
9.1.2 Latin America Generic Drugs Revenue by Type (2019-2027)
9.2 Latin America Generic Drugs Market Size by Application
9.2.1 Latin America Generic Drugs Sales by Application (2019-2027)
9.2.2 Latin America Generic Drugs Revenue by Application (2019-2027)
9.3 Latin America Generic Drugs Market Size by Country
9.3.1 Latin America Generic Drugs Sales by Country (2019-2027)
9.3.2 Latin America Generic Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Generic Drugs Market Size by Type
6.1.1 Middle East and Africa Generic Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Generic Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Generic Drugs Market Size by Application
6.2.1 Middle East and Africa Generic Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Generic Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Generic Drugs Market Size by Country
6.3.1 Middle East and Africa Generic Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Generic Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Teva Generic Drugs Product Description
11.1.5 Teva Related Developments
11.2 Novartis – Sandoz
11.2.1 Novartis – Sandoz Corporation Information
11.2.2 Novartis – Sandoz Overview
11.2.3 Novartis – Sandoz Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Novartis – Sandoz Generic Drugs Product Description
11.2.5 Novartis – Sandoz Related Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Mylan Generic Drugs Product Description
11.3.5 Mylan Related Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sun Pharmaceutical Generic Drugs Product Description
11.4.5 Sun Pharmaceutical Related Developments
11.5 Aspen
11.5.1 Aspen Corporation Information
11.5.2 Aspen Overview
11.5.3 Aspen Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Aspen Generic Drugs Product Description
11.5.5 Aspen Related Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Corporation Information
11.6.2 Fresenius Kabi Overview
11.6.3 Fresenius Kabi Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Fresenius Kabi Generic Drugs Product Description
11.6.5 Fresenius Kabi Related Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Corporation Information
11.7.2 Pfizer (Hospira) Overview
11.7.3 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Pfizer (Hospira) Generic Drugs Product Description
11.7.5 Pfizer (Hospira) Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sanofi Generic Drugs Product Description
11.8.5 Sanofi Related Developments
11.9 Aurobindo
11.9.1 Aurobindo Corporation Information
11.9.2 Aurobindo Overview
11.9.3 Aurobindo Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Aurobindo Generic Drugs Product Description
11.9.5 Aurobindo Related Developments
11.10 Lupin
11.10.1 Lupin Corporation Information
11.10.2 Lupin Overview
11.10.3 Lupin Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Lupin Generic Drugs Product Description
11.10.5 Lupin Related Developments
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Teva Generic Drugs Product Description
11.1.5 Teva Related Developments
11.12 Apotex
11.12.1 Apotex Corporation Information
11.12.2 Apotex Overview
11.12.3 Apotex Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Apotex Product Description
11.12.5 Apotex Related Developments
11.13 Cipla
11.13.1 Cipla Corporation Information
11.13.2 Cipla Overview
11.13.3 Cipla Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Cipla Product Description
11.13.5 Cipla Related Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Corporation Information
11.14.2 ENDO (Par Pharmaceutical) Overview
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 ENDO (Par Pharmaceutical) Product Description
11.14.5 ENDO (Par Pharmaceutical) Related Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Corporation Information
11.15.2 Stada Arzneimittel Overview
11.15.3 Stada Arzneimittel Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Stada Arzneimittel Product Description
11.15.5 Stada Arzneimittel Related Developments
11.16 Krka Group
11.16.1 Krka Group Corporation Information
11.16.2 Krka Group Overview
11.16.3 Krka Group Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Krka Group Product Description
11.16.5 Krka Group Related Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Corporation Information
11.17.2 Nichi-Iko Pharmaceutical Overview
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Nichi-Iko Pharmaceutical Product Description
11.17.5 Nichi-Iko Pharmaceutical Related Developments
11.18 Valeant
11.18.1 Valeant Corporation Information
11.18.2 Valeant Overview
11.18.3 Valeant Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 Valeant Product Description
11.18.5 Valeant Related Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Corporation Information
11.19.2 Zydus Cadila Overview
11.19.3 Zydus Cadila Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.19.4 Zydus Cadila Product Description
11.19.5 Zydus Cadila Related Developments
11.20 Hikma
11.20.1 Hikma Corporation Information
11.20.2 Hikma Overview
11.20.3 Hikma Generic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.20.4 Hikma Product Description
11.20.5 Hikma Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Generic Drugs Value Chain Analysis
12.2 Generic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Generic Drugs Production Mode & Process
12.4 Generic Drugs Sales and Marketing
12.4.1 Generic Drugs Sales Channels
12.4.2 Generic Drugs Distributors
12.5 Generic Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Generic Drugs Industry Trends
13.2 Generic Drugs Market Drivers
13.3 Generic Drugs Market Challenges
13.4 Generic Drugs Market Restraints

14 Key Findings in The Global Generic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Download Full Report – https://qyresearchmedical.com/report/checkout/98919/3500

Contact Us:

QYResearch Medical

Mailing Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Any Assistance, Email – sales@qyresearchmedical.com

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

View all posts by Steve Robber →

Leave a Reply

Your email address will not be published. Required fields are marked *